Sort
48,018 grants matching “immunotherapy”
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
$1,176,407Joaquin M. Espinosa · University Of Colorado Denver · R61 · FY2023 · HD
IN VIVO 31P MRS STUDIES OF NON-HODGKIN'S LYMPHOMA
$1,174,250Truman R. Brown · Columbia University Health Sciences · R01 · FY2008 · CA
ANTIGEN SPECIFIC THERAPY IN CNS AUTOIMMUNE DISEASES
$1,174,045Brigham And Women'S Hospital · P01 · FY2002 · NS
A FUSION PROTEIN BISPECIFIC PHAGOCYTE ENGAGER (BIPE) FOR TARGETED BREAST CANCER IMMUNOTHERAPY
$1,173,750The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2019 · Department of the Army
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
$1,173,739Jonathan P Schneck · Johns Hopkins University · P41 · FY2020 · EB
Vaccine Clinical Trials
$1,173,524James L. Gulley · Basic Sciences · Z01 · FY2007 · CA
Vaccine Clinical Trials
$1,173,524Philip M Arlen · Basic Sciences · Z01 · FY2007 · CA
Immuno/Immunogene Therapies for Thoracic Malignancies
$1,173,204Steven Mark Albelda · University Of Pennsylvania · P01 · FY2006 · CA
Sonogenetic Remote Control of Cellular Function
$1,172,500Mikhail Shapiro · California Institute Of Technology · DP1 · FY2024 · EB
Sonogenetic Remote Control of Cellular Function
$1,172,500Mikhail Shapiro · California Institute Of Technology · DP1 · FY2025 · EB
Sonogenetic Remote Control of Cellular Function
$1,172,500Mikhail Shapiro · California Institute Of Technology · DP1 · FY2023 · EB
Sonogenetic Remote Control of Cellular Function
$1,172,500Mikhail Shapiro · California Institute Of Technology · DP1 · FY2021 · EB
Sonogenetic Remote Control of Cellular Function
$1,172,500Mikhail Shapiro · California Institute Of Technology · DP1 · FY2022 · EB
Cell Production Core Facility
$1,172,145Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Surgery Branch Cell Prep Core
$1,172,143John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$1,171,708James S Duncan · Yale University · R01 · FY2025 · CA
Cellular Vaccines for Cancer Therapy
$1,171,386University Of Michigan At Ann Arbor · P01 · FY2003 · CA
Role of neurokinin 1 receptor signaling in keratinocytes in allergic contact dermatitis
$1,171,154Adriana T Larregina · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$1,170,759Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Determine the molecular and metabolic mechanisms by which A-FABP links dysregulated lipid metabolism-induced obesity/breast cancer risk
$1,170,632Bing Li · University Of Iowa · U01 · FY2025 · CA
Novel Targets for Immunotherapy
$1,170,238Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
$1,170,205Terry B Gernsheimer · University Of Washington · U01 · FY2016 · HL
REPURPOSING ANTIESTROGENS TO PRIME THE IMMUNE SYSTEM FOR BREAST CANCER IMMUNOTHERAPY
$1,170,000University Of California, Los Angeles · · FY2019 · Defense Health Agency
Combinational Immunotherapies to Amplify Vaccine Induce*
$1,169,956Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2006 · CA
REGULATION OF ANTI-TUMOR IMMUNITY
$1,169,175Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2008 · CA